α-Synuclein aggregates in corticostriatal terminals impair glutamatergic transmission in the absence of neurodegeneration
This study demonstrates that early alpha-synuclein aggregation in corticostriatal terminals impairs glutamatergic transmission and reduces synaptic density without causing neuronal degeneration, highlighting presynaptic dysfunction as a critical early therapeutic target in Lewy body diseases.